ICL Clinical Trials

78 recruitingLast updated: July 25, 2026

There are 78 actively recruiting icl clinical trials across 34 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Boston, Massachusetts, United States, Philadelphia, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


ICL Trials at a Glance

78 actively recruiting trials for icl are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Not Applicable with 31 trials, with the heaviest enrollment activity in New York, Boston, and Philadelphia. Lead sponsors running icl studies include ApaTech Ltd, Beijing Anzhen Hospital, and Centre Hospitalier Universitaire, Amiens.

Treatments under study

About ICL Clinical Trials

Looking for clinical trials for ICL? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ICL trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ICL clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 78 trials

Recruiting

Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

EpilepsyPET / MRSynaptic Vesicle Proteins+2 more
Weibing Miao, PhD60 enrolled1 locationNCT07147309
Recruiting

PRecision Integrated Saturation Monitor

Single Ventricle Heart DiseaseCHD - Congenital Heart Disease
Le Bonheur Children's Hospital100 enrolled1 locationNCT07686341
Recruiting
Not Applicable

Fluoroscopic Endobutton in Clavicle Fractures and AC Dislocations

Clavicle Fracture
BOUCHRA BENKESSOU10 enrolled1 locationNCT07664202
Recruiting
Phase 2

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Breast CancerColorectal, CancerLung Cancer+13 more
Brigham and Women's Hospital134 enrolled2 locationsNCT04899908
Recruiting
Not Applicable

Indomethacin vs Diclofenac for Preventing PEP

PancreatitisERCPNon-steroidal Anti-inflammatory (NSAID)+2 more
Air Force Military Medical University, China4,050 enrolled20 locationsNCT07071441
Recruiting
Not Applicable

The Effect of Consumed Berries on Extracellular Vesicle Signalling in the Body

HealthyExtracellular Vesicles
University of Oulu60 enrolled1 locationNCT07381933
Recruiting
Phase 4

Pediatric Long-Term Follow-up and Rollover Study

Neurofibromatosis Type 1GlioblastomaAnaplastic Astrocytoma+20 more
Novartis Pharmaceuticals165 enrolled55 locationsNCT03975829
Recruiting
Early Phase 1

Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye Disease

Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular VesiclesDry-Eye Disease
The First Affiliated Hospital of Xiamen University20 enrolled1 locationNCT07623382
Recruiting
Not Applicable

Assessment of Soft Tissue Thickness Over Zygomatic Implants in Atrophied Maxilla Covered With Buccal Fat Pad vs. Palatal Pedicle Flap

Dental ImplantSoft Tissue Augmentation at Dental ImplantsZygomatic Implants+5 more
Future University in Egypt4 enrolled1 locationNCT07574606
Recruiting
Not Applicable

Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology

Single Ventricle
Driscoll Children's Hospital100 enrolled1 locationNCT07087782
Recruiting
Phase 2

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study

Breast NeoplasmsBreast DiseasesCDK4/6 Inhibitor+3 more
Fujian Cancer Hospital2,000 enrolled2 locationsNCT07581834
Recruiting
Phase 2

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

HFpEF - Heart Failure With Preserved Ejection FractionFontan CirculationSingle Ventricle Heart Disease
Mayo Clinic27 enrolled1 locationNCT06762964
Recruiting
Phase 2

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Breast CancerNeutropenia (Low White Blood Cell Count)Leucogen+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University94 enrolled1 locationNCT07380646
Recruiting
Phase 4

Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

Contrast Enhanced Images vs. Non-contrast ImagesGadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images
UConn Health10 enrolled1 locationNCT06846853
Recruiting
Not Applicable

Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis

OsteoporosisFemale InfertilityNF-κB Ligand+2 more
Peter Humaidan100 enrolled1 locationNCT07546552
Recruiting
Not Applicable

Fontan Fitness Trial

Congenital Heart DiseaseSingle Ventricle
Children's Hospital of Philadelphia200 enrolled1 locationNCT06918795
Recruiting
Not Applicable

Study and Modeling of Perforator Flap Vascularization

Reconstructive Surgery Using Pedicled Perforating or Free Perforating FlapsPelvic EscharTraumatic Pathology of the Lower and/or Upper Limb
University Hospital, Montpellier20 enrolled1 locationNCT07084740
Recruiting

Repeated Examinations for Typing Pulmonary Embolism

Pulmonary Embolism (PE)Pulmonary Embolism (Diagnosis)Pulmonary Embolism Acute+2 more
Sahlgrenska University Hospital400 enrolled3 locationsNCT07491094
Recruiting

Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea

Breast NeoplasmsAbemaciclibHormone Receptor-Positive Breast Cancer+4 more
Hubei Cancer Hospital60 enrolled1 locationNCT07264998
Recruiting
Phase 1

Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors

TrilaciclibCDK4/6-dependent Solid Tumors
Hebei Medical University Fourth Hospital100 enrolled1 locationNCT07490236